Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children’s Oncology Group

2013208 citationsJournal Articlebronze Open Access

Authors

Gregory A. Yanik · Michigan Medicine

Marguerite T. Parisi · Seattle Children's Hospital

Barry L. Shulkin · St. Jude Children's Research Hospital

Arlene Naranjo · University of Florida

Susan G. Kreissman · Duke Medical Center

Wendy B. London · Children's Oncology Group

Judith G. Villablanca

Abstract

Curie scoring carries prognostic significance in the management of patients with high-risk neuroblastoma. In particular, patients with CSs > 2 after induction have extremely poor outcomes and should be considered for alternative therapeutic strategies.

Topics & Keywords

Neuroblastoma Research and Treatments Neurofibromatosis and Schwannoma Cases Adrenal and Paraganglionic Tumors

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Nuclear Medicine

Volume 54, Issue 4, pp. 541-548

DOI: 10.2967/jnumed.112.112334

Field-Weighted Citation Impact: 10.02